Clinical Genetics
Science
Our Foundation funds cutting edge research to benefit those with FBXO31
Our Partners
The Research
n-Lorem Foundation
October, 2025
Foundation research efforts identified FBXO31 disease as a candidate for ASO drug therapy, 2 patients enrolled.
Perlara’s Cure Odysseys
Jan 13, 2025
FBXO31 Cure Roadmap
The first step toward a cure is a treatment, and the first step toward a treatment is a research roadmap.
EVERY CURE
Leucovorin may help with improving verbal communication in certain individuals with ASD who have a vitamin deficiency
American Neurological Association: Annals of Clinical and Translational Neurology
February 2021
Variant recurrence confirms the existence of a FBXO31-related spastic-dystonic cerebral palsy syndrome
The University of Arizona: University Libraries